1MED’s New Partnership with Accenture!

We are thrilled to announce a game-changing collaboration between 1MED, a leading

Discovery Pack – MDD to MDR

MDR Grace Period ends May 26th 2024. As this date approaches, manufacturers

An insight on the improvements in the medical devi...

From today we start the distribution of our video in the US

TOP 5 most urgent tasks for MDR compliance before ...

Following the success of the 1TALK event on November 30th, 1MED team

DISPOSITIVI MEDICI E DATI CLINICI – focus su...

1MED ha proposto il webinar 1TALK  “Dispositivi medici e dati clinici, focus sui

1MED and Apposite Capital partner to support excel...

Apposite Capital, the healthcare specialist private equity investor, today announces that it

Generation of compliant, pre-clinical, biocompatib...

The approach to biological evaluation for medical devices has significantly changed in

1MED featured as top 10 pharma and life science ou...

1MED’s CEO, Enrico Perfler, was interviewed by Pharmatech Outlook, a major print

1MED INNOVATION DIGITAL FORUM

Il 3 Luglio si è tenuto il primo 1MED INNOVATION DIGITAL FORUM,

Clinical data and clinical evidence requirements u...

Compared to the old Directives, the new Medical Device Regulation (MDR) reinforces